Chelsea Therapeutics Class Action Securities Lawsuit | (888) 252-0048

If you or someone you know suffered a net loss for all transactions in Chelsea Therapeutics International, Ltd. (CHTP) common stock during the Class Period, you are encouraged to contact our Shareholder Rights Attorneys to obtain additional information about this lawsuit and your ability to become a lead plaintiff. You may contact our experienced securities law attorneys by telephone toll free at (888) 252-0048, by e-mail at consultations@gilmanlawllp.com, or by completing the yellow form to the left of this screen for a free class action consultation. You may retain the leading national securities law firm of Gilman Law LLP to represent you in this matter without financial obligation or cost to you.

No class has yet been certified in the above action. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement and how much of a settlement to accept for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the Company during the Class Period. You are not required to have sold your shares to seek damages or to serve as a Lead Plaintiff.

To join in or read more about the Enterprise Financial Services Corp. Class Action Securities Lawsuit.

If you or someone you know suffered a net loss for all transactions in Enterprise Financial Services Corp. (EFSC) common stock during the Class Period mentioned above, you are encouraged to contact our Shareholder Rights Attorneys to obtain additional information about this lawsuit and your ability to become a lead plaintiff. You may contact our experienced securities law attorneys by telephone toll free at (888) 252-0048, by e-mail at consultations@gilmanlawllp.com, or by completing the yellow form to the left of this screen for a free class action consultation. You may retain the leading national securities law firm of Gilman Law LLP to represent you in this matter without financial obligation or cost to you.

No class has yet been certified in the above action. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement and how much of a settlement to accept for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the Company during the Class Period. You are not required to have sold your shares to seek damages or to serve as a Lead Plaintiff.

To join in or read more about the Enterprise Financial Services Corp. Class Action Securities Lawsuit.

Terms of the eResearch Technology Acquisition

Under the terms of the agreement, ERT shareholders will receive $8.00 in cash for each share they own. The investigation is focused on the potential unfairness of the price to ERT shareholders and the process by which the ERT Board of Directors considered and approved the transaction.

How To Receive Compensation or Protect Your Rights as an eResearch Technology Shareholder

To discuss your rights as an ERT shareholder, with no obligation or cost to you, please contact Thomas E. N. Shea toll free at (888) 252-0048 or by e-mail tshea@gilmanpastor.com. You may also complete the Free eResearch Technology (ERT) Consultation Form to speak with a securities law attorney.

How To Join The Groupon Lawsuit

Gilman Law LLP, a national securities law firm with over 33 years of experience in complex securities litigation, announces a lawsuit concerning possible violations of the federal securities laws by Groupon, Inc. (NASDAQ:GRPN) regarding whether Groupon may have issued materially false and/or misleading information to investors, including in connection with its initial public offering (IPO) of shares to the public on November 4, 2011.

The investigation arises from the Company’s announcement that it is revising its reported financial results for the fourth quarter and year ended December 31, 2011. Groupon announced that the Company’s fourth quarter revenue was being reduced by $14.3 million, its fourth quarter operating income reduced by $30 million, its net income reduced by $22.6 million, and its earnings per share reduced by $0.04 per share and from a statement of “material weakness” regarding Groupon’s (NASDAQ:GRPN) internal financial controls issued by the Company’s auditor, Ernst & Young LLP.

How To Join The Groupon Lawsuit

If you purchased Groupon, Inc. (NASDAQ:GRPN) shares between the offering date (IPO date) of November 4, 2011 and March 31, 2012 and would like to learn more about joining this lawsuit, you may contact the Gilman National Securities Law Firm toll free at (888) 252-0048 so that our experienced securities law attorneys can attempt to answer your questions with no charge or obligation to you. You may also contact Gilman Law LLP by email at consultations@gilmanlawllp.com, or by clicking the following link to submit a request for a Free Groupon Lawsuit Consultation.

On February 21, 2012, ATSC and Salient announced they had entered into a definitive merger agreement, with the transaction to be financed from Salient’s equity capital commitments and debt financing. The cash tender offer is valued at about $77 million. Under the terms of the proposed transaction, ATSC shareholders will receive $3.20 in cash for each share they own. Read more about the ATSC Breach of Fiduciary Duty Investigation.

The National Securities Law Firm Gilman Law LLP is investigating claims for breach of fiduciary duty by the board of directors of ATS Corporation to Salient Federal Solutions. To speak with a securities attorney regarding the ATSC breach of fiduciary duty investigation, please contact our office at (239) 221-8301 or complete our free consultation form online.

The National Securities Law Firm Gilman Law LLP is investigating potential breach of fiduciary

Investigation of Midas, Inc. for Potential Breach of Fiduciary Duty

claims by current shareholders of Midas, Inc. (“Midas”) (NYSE: MDS) against the board of directors of Midas in connection with their efforts to sell the Company to TBC Corporation in a transaction valued at approximately $310 million.

On March 13, 2012, Midas announced that it had entered into a definitive merger agreement to be acquired by TBC Corporation.  According to the terms of the deal, Midas shareholders will receive $11.50 in cash for each share of MDS stock owned. Gilman Law is investigating whether Midas shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues Midas stock, and whether Midas’ board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal.

If you are a current shareholder of Midas and would like to learn more about the breach of fiduciary duty investigation by the National Securities Law Firm Gilman Law LLP, you may contact our office for a free consultation by calling (239) 221-8301 or complete our free consultation form online. 

About the National Securities Law Firm Gilman Law LLP

The leading national securities law attorneys at Gilman Law have over 32 years of experience litigating securities and other class action cases. Our firm has been involved in all major aspects of securities litigation, including cases involving stock manipulation, securities fraud, investment fraud, and shareholder rights violations, as well as securities class action suits on behalf of both individual and institutional investors.

Investigation into Zoll Medical Acquisition by Asahi Kasei

On March 12, 2012, Zoll and Asahi announced that they had entered into a definitive agreement providing for Asahi to acquire Zoll for approximately $2.1 billion. Under the terms of the Zoll acquisition merger agreement, Zoll shareholders will receive $93.00 for each share of Zoll common stock held. However, according to news media, at least one analyst has set a high price target of $100.00 per share. The transaction is expected to close in the second calendar quarter of 2012. Read more about the Zoll Medical Breach of Fiduciary Duty Investigation.

The National Securities Law Firm Gilman Law LLP is investigating claims for breach of fiduciary duty by the board of directors of Zoll Medical concernin this acquisition by Asahi Kasei. To speak with a securities attorney regarding the Zoll Medical breach of fiduciary duty investigation, please contact our office at (239) 221-8301 or complete our free consultation form online.

Leading National Securities Law Firm Gilman Law LLP Investigating State Street's Carina CDO Ltd.

Leading National Securities Law Firm Gilman Law LLP is investigating claims on behalf of investors that lost money in State Street’s Carina CDO Ltd. State Street was recently fined $5 million by Massachusetts Securities Division. Upon information and belief, State Street failed to disclose to its Carina CDO Ltd. Investors that the Magnetar Capital LLC hedge fund played a role in structuring the CDO. Unbeknownst to investors, State Street knew that Magnetar was in fact betting against at least a portion of the Carina CDO investment. Such material information should have been disclosed to potential investors of the Carina CDO. Investors lost approximately $450 million in the Carina CDO Ltd. investment.

The Leading National Securities Law Firm Gilman Law LLP is here to help you recover for your State Street investment losses. For a free evaluation of your case, please fill out our online free consultation form, or if you need to speak with an attorney right away CALL TOLL FREE (1-888-252-0048).

Gilman Law LLP is investigating claims on behalf of investors suffering losses of $500,000 or more in Credit Suisse structured products. The Securities and Exchange Commission (“SEC”) recently filed a complaint against four Credit Suisse investment bankers and structured credit traders. The complaint alleges that the structured product traders inflated the prices of certain bonds masking losses. The traders’ misconduct caused purchasers of these products to pay inflated prices. If you have suffered losses of $500,000 or more you may have a claim for damages.

About the Securities Lawyers at Gilman Law LLP

The National Securities Law Firm Gilman Law LLP is a leading securities law firm and is here to help you recover for structured product losses. For a free evaluation of your case, please fill out our free consultation form, or if you need to speak with a securities law attorney right away CALL (1-239-221-8301).

Gilman Law LLP is a leading securities law firm and is here to help you recover for losses due to excessive commissions. For a free evaluation of your case, please fill out our online form, or if you need to speak with an attorney right away, CALL (1-239-221-8301).